Analyze Diet
Journal of veterinary internal medicine2004; 18(4); 568-573; doi: 10.1892/0891-6640(2004)18<568:rcoaca>2.0.co;2

Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia.

Abstract: The objective of this retrospective study was to compare the efficacy of azithromycin-rifampin, clarithromycin-rifampin, and erythromycin-rifampin for the treatment of pneumonia caused by Rhodococcus equi in foals. Eighty-one foals with naturally acquired pneumonia caused by R. equi were included in the study. Information on age, sex, breed, physical examination findings, laboratory testing, and thoracic radiography was abstracted from each medical record. Foals were divided in 3 groups based on the antimicrobial agent selected for therapy. Short-term (discharge from the hospital) and long-term (apparently healthy as a yearling) success rates, days of hospitalization, days with fever, days with tachypnea, and percentage of radiographic improvement were compared among groups. Foals treated with clarithromycin-rifampin had significantly (P = .02) higher odds of overall short-term (odds ratio [OR] = 12.2) and long-term (OR = 20.6) treatment success and significantly fewer days with fever than foals treated with erythromycin-rifampin. Foals treated with clarithromycin-rifampin had a significantly (P = .03) higher percentage of radiographic improvement and a tendency (P = .06) toward higher odds of overall short-term (OR = 8.1) and long-term (OR = 11.8) treatment success compared to foals treated with azithromycin-rifampin. Among foals with severe radiographic lesions, the success rates of foals treated with clarithromycin-rifampin both short-term (88%) and long-term (83%) were significantly (P = .02) higher than that of foals treated with azithromycin-rifampin (0%). For each treatment group, the only reported adverse effect was diarrhea that was mild and self-limiting in most cases. The combination clarithromycin-rifampin is superior to azithromycin-rifampin or erythromycin-rifampin for the treatment of pneumonia caused by R. equi in foals in a referral population.
Publication Date: 2004-08-24 PubMed ID: 15320600DOI: 10.1892/0891-6640(2004)18<568:rcoaca>2.0.co;2Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Evaluation Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research aims to compare the effectiveness of three types of antibiotics in treating a particular type of pneumonia in foals. The study concluded that the use of clarithromycin-rifampin proves to be the most effective amongst the three in treating pneumonia caused by Rhodococcus equi.

Objective of the Study

  • The research was designed as a retrospective study to compare and contrast the efficiency of azithromycin-rifampin, clarithromycin-rifampin, and erythromycin-rifampin. These were used for treating pneumonia induced by the bacterium Rhodococcus equi in foals.

Methodology and Parameters

  • The study enlisted 81 foals that had naturally contracted pneumonia caused by R. equi.
  • Data was collected through multiple sources such as medical records, including particulars like age, sex, breed, physical examination results, laboratory testing, and thoracic radiography.
  • The foals were divided into three groups, each treated with one of the three antibiotic combinations.
  • Various outcomes were compared across these groups, including short-term (discharge from the hospital) and long-term (good health as a yearling) success rates, days of hospitalization, days with fever, days with tachypnea, and percentage of radiographic improvement.

Findings of the Study

  • The study found that foals treated with clarithromycin-rifampin had significantly higher odds of both short-term and long-term treatment success, and fewer days with fever, than those treated with erythromycin-rifampin.
  • Moreover, the foals treated with clarithromycin-rifampin also had a significantly higher percentage of radiographic improvement and a tendency towards better overall short-term and long-term treatment success compared to foals treated with azithromycin-rifampin.
  • In severe cases with complicated radiographic lesions, treatment success rates were significantly higher for foals treated with clarithromycin-rifampin, both in the short-term and in the long-term, compared to those treated with azithromycin-rifampin.
  • Across all treatment groups, the only reported side effect was mild, self-limiting diarrhea.

Conclusion

  • The findings suggest that the combination of clarithromycin and rifampin is superior to either azithromycin-rifampin or erythromycin-rifampin when it comes to treating pneumonia caused by R. equi in foals.

Cite This Article

APA
Giguère S, Jacks S, Roberts GD, Hernandez J, Long MT, Ellis C. (2004). Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J Vet Intern Med, 18(4), 568-573. https://doi.org/10.1892/0891-6640(2004)18<568:rcoaca>2.0.co;2

Publication

ISSN: 0891-6640
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 18
Issue: 4
Pages: 568-573

Researcher Affiliations

Giguère, Steeve
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA. gigueres@mail.vetmed.ufl.edu
Jacks, Stephanie
    Roberts, Gregory D
      Hernandez, Jorge
        Long, Maureen T
          Ellis, Christina

            MeSH Terms

            • Actinomycetales Infections / drug therapy
            • Actinomycetales Infections / veterinary
            • Animals
            • Animals, Newborn
            • Anti-Bacterial Agents / administration & dosage
            • Azithromycin / administration & dosage
            • Clarithromycin / administration & dosage
            • Erythromycin / administration & dosage
            • Female
            • Florida / epidemiology
            • Horse Diseases / diagnostic imaging
            • Horse Diseases / drug therapy
            • Horse Diseases / epidemiology
            • Horse Diseases / pathology
            • Horses
            • Male
            • Pneumonia, Bacterial / drug therapy
            • Pneumonia, Bacterial / veterinary
            • Radiography
            • Records / veterinary
            • Retrospective Studies
            • Rhodococcus equi
            • Severity of Illness Index
            • Treatment Outcome

            Citations

            This article has been cited 18 times.
            1. Liu L, Yu W, Cai K, Ma S, Wang Y, Ma Y, Zhao H. Identification of vaccine candidates against rhodococcus equi by combining pangenome analysis with a reverse vaccinology approach.. Heliyon 2023 Aug;9(8):e18623.
              doi: 10.1016/j.heliyon.2023.e18623pubmed: 37576287google scholar: lookup
            2. Zúñiga MP, Badillo E, Abalos P, Valencia ED, Marín P, Escudero E, Galecio JS. Antimicrobial susceptibility of Rhodococcus equi strains isolated from foals in Chile.. World J Microbiol Biotechnol 2023 Jun 22;39(9):231.
              doi: 10.1007/s11274-023-03677-2pubmed: 37347336google scholar: lookup
            3. Rakowska A, Marciniak-Karcz A, Bereznowski A, Cywińska A, Żychska M, Witkowski L. Less Typical Courses of Rhodococcus equi Infections in Foals.. Vet Sci 2022 Oct 31;9(11).
              doi: 10.3390/vetsci9110605pubmed: 36356082google scholar: lookup
            4. Patterson Rosa L, Mallicote MF, MacKay RJ, Brooks SA. Ion Channel and Ubiquitin Differential Expression during Erythromycin-Induced Anhidrosis in Foals.. Animals (Basel) 2021 Nov 25;11(12).
              doi: 10.3390/ani11123379pubmed: 34944156google scholar: lookup
            5. Rakowska A, Cywinska A, Witkowski L. Current Trends in Understanding and Managing Equine Rhodococcosis.. Animals (Basel) 2020 Oct 18;10(10).
              doi: 10.3390/ani10101910pubmed: 33081047google scholar: lookup
            6. Ejuh GW, Fonkem C, Tadjouteu Assatse Y, Yossa Kamsi RA, Nya T, Ndukum LP, Ndjaka JMB. Study of the structural, chemical descriptors and optoelectronic properties of the drugs Hydroxychloroquine and Azithromycin.. Heliyon 2020 Aug;6(8):e04647.
              doi: 10.1016/j.heliyon.2020.e04647pubmed: 32802983google scholar: lookup
            7. Ruocco NA 3rd, Luedke LK, Fortier LA, Ducharme NG, Reesink HL. Rhodococcus equi Joint Sepsis and Osteomyelitis Is Associated With a Grave Prognosis in Foals.. Front Vet Sci 2019;6:503.
              doi: 10.3389/fvets.2019.00503pubmed: 31993449google scholar: lookup
            8. Trevisani MM, Hanna ES, Oliveira AF, Cardoso SA, Roque-Barreira MC, Soares SG. Vaccination of Mice with Virulence-Associated Protein G (VapG) Antigen Confers Partial Protection against Rhodococcus equi Infection through Induced Humoral Immunity.. Front Microbiol 2017;8:857.
              doi: 10.3389/fmicb.2017.00857pubmed: 28553279google scholar: lookup
            9. Rutenberg D, Venner M, Giguère S. Efficacy of Tulathromycin for the Treatment of Foals with Mild to Moderate Bronchopneumonia.. J Vet Intern Med 2017 May;31(3):901-906.
              doi: 10.1111/jvim.14717pubmed: 28421633google scholar: lookup
            10. Giguère S, Berghaus LJ, Miller CD. Clinical Assessment of a Point-of-Care Serum Amyloid A Assay in Foals with Bronchopneumonia.. J Vet Intern Med 2016 Jul;30(4):1338-43.
              doi: 10.1111/jvim.13978pubmed: 27296082google scholar: lookup
            11. Cohen ND, Slovis NM, Giguère S, Baker S, Chaffin MK, Bernstein LR. Gallium maltolate as an alternative to macrolides for treatment of presumed Rhodococcus equi pneumonia in foals.. J Vet Intern Med 2015 May-Jun;29(3):932-9.
              doi: 10.1111/jvim.12595pubmed: 25868480google scholar: lookup
            12. Burton AJ, Giguère S, Berghaus LJ, Hondalus MK. Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice.. Antimicrob Agents Chemother 2015;59(6):3633-6.
              doi: 10.1128/AAC.04941-14pubmed: 25824218google scholar: lookup
            13. Hildebrand F, Venner M, Giguère S. Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumonia.. J Vet Intern Med 2015 Jan;29(1):333-8.
              doi: 10.1111/jvim.12504pubmed: 25619521google scholar: lookup
            14. Berghaus LJ, Giguère S, Guldbech K, Warner E, Ugorji U, Berghaus RD. Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi.. J Clin Microbiol 2015 Jan;53(1):314-8.
              doi: 10.1128/JCM.02673-14pubmed: 25378571google scholar: lookup
            15. Rivulgo V, Sparo M, Ceci M, Fumuso E, Confalonieri A, Delpech G, Bruni SF. Comparative plasma exposure and lung distribution of two human use commercial azithromycin formulations assessed in murine model: a preclinical study.. Biomed Res Int 2013;2013:392010.
              doi: 10.1155/2013/392010pubmed: 24073402google scholar: lookup
            16. Schlusselhuber M, Jung S, Bruhn O, Goux D, Leippe M, Leclercq R, Laugier C, Grötzinger J, Cauchard J. In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.. Antimicrob Agents Chemother 2012 Apr;56(4):1749-55.
              doi: 10.1128/AAC.05797-11pubmed: 22232283google scholar: lookup
            17. Coulson GB, Agarwal S, Hondalus MK. Characterization of the role of the pathogenicity island and vapG in the virulence of the intracellular actinomycete pathogen Rhodococcus equi.. Infect Immun 2010 Aug;78(8):3323-34.
              doi: 10.1128/IAI.00081-10pubmed: 20439471google scholar: lookup
            18. Schnellmann C, Gerber V, Rossano A, Jaquier V, Panchaud Y, Doherr MG, Thomann A, Straub R, Perreten V. Presence of new mecA and mph(C) variants conferring antibiotic resistance in Staphylococcus spp. isolated from the skin of horses before and after clinic admission.. J Clin Microbiol 2006 Dec;44(12):4444-54.
              doi: 10.1128/JCM.00868-06pubmed: 17005735google scholar: lookup